Robert J Coffey Selected Research

CCT239065

3/2013

3'-Deoxy-3'-18F-fluorothymidine PET predicts response to (V600E)BRAF-targeted therapy in preclinical models of colorectal cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Robert J Coffey Research Topics

Disease

55	Neoplasms (Cancer) 01/2022 - 02/2002
42	Colorectal Neoplasms (Colorectal Cancer) 12/2022 - 02/2002
11	Carcinogenesis 01/2019 - 02/2002
8	Neoplasm Metastasis (Metastasis) 12/2022 - 11/2003
8	Colonic Neoplasms (Colon Cancer) 02/2022 - 03/2004
7	Adenoma (Adenomas) 01/2022 - 02/2002
7	Metaplasia 01/2019 - 04/2003
6	Inflammation (Inflammations) 01/2022 - 04/2007
6	Carcinoma (Carcinomatosis) 01/2018 - 02/2002
4	Chronic Pain 07/2014 - 12/2002
4	Pain (Aches) 09/2013 - 12/2002
3	Stomach Neoplasms (Stomach Cancer) 01/2022 - 01/2013
3	Infections 01/2021 - 06/2004
3	Nausea 09/2013 - 07/2005
3	Atrophy 12/2012 - 05/2005
2	Disease Progression 12/2022 - 06/2010
2	Polyps 12/2021 - 11/2006
2	Cysts 01/2021 - 01/2017
2	Necrosis 10/2020 - 03/2004
2	Rectal Neoplasms (Rectal Cancer) 07/2015 - 11/2006
2	Adenocarcinoma 01/2015 - 12/2005
2	Edema (Dropsy) 09/2013 - 07/2005
2	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 10/2012 - 06/2010
2	Vomiting 12/2010 - 07/2005
2	Respiratory Insufficiency (Respiratory Failure) 07/2010 - 10/2009
2	Polycystic Kidney Diseases (Polycystic Kidney Disease) 06/2010 - 02/2004
2	Hemorrhage 06/2010 - 07/2005
2	Autosomal Recessive Polycystic Kidney (Polycystic Kidney Disease, Infantile, Type I) 03/2008 - 02/2004
2	Psoriasis (Pustulosis Palmaris et Plantaris) 09/2005 - 06/2005
1	Mood Disorders (Mood Disorder) 01/2022
1	Alzheimer Disease (Alzheimer's Disease) 12/2021
1	Cardiovascular Diseases (Cardiovascular Disease) 12/2021

Drug/Important Bio-Agent (IBA)

25	Proteins (Proteins, Gene)FDA Link 10/2021 - 11/2003
13	Cetuximab (Erbitux)FDA Link 12/2022 - 07/2005
11	ErbB Receptors (EGF Receptor)IBA 12/2022 - 02/2002
9	Biomarkers (Surrogate Marker)IBA 12/2018 - 11/2006
8	LigandsIBA 01/2022 - 03/2002
7	Pharmaceutical PreparationsIBA 01/2018 - 06/2004
7	Cadherins (E-Cadherin)IBA 12/2017 - 11/2003
7	Transforming Growth Factor alpha (TGF-alpha)IBA 02/2008 - 07/2004
6	AmphiregulinIBA 04/2015 - 06/2005
5	Biological ProductsIBA 12/2022 - 12/2005
4	Calcibiotic Root Canal SealerIBA 12/2021 - 11/2006
4	Epidermal Growth Factor (EGF)IBA 01/2021 - 04/2003
4	spasmolytic polypeptideIBA 01/2019 - 05/2007
4	ProteomeIBA 10/2018 - 03/2004
4	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 12/2011 - 04/2003
4	Opioid Analgesics (Opioids)IBA 07/2010 - 12/2002
4	ProstaglandinsIBA 11/2006 - 09/2002
3	Messenger RNA (mRNA)IBA 12/2022 - 01/2013
3	Monoclonal AntibodiesIBA 12/2022 - 05/2017
3	Glutamine (L-Glutamine)FDA Link 01/2022 - 01/2018
3	MicroRNAs (MicroRNA)IBA 12/2021 - 10/2018
3	IntegrinsIBA 01/2021 - 02/2013
3	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2021 - 04/2003
3	Leucine (L-Leucine)FDA Link 01/2019 - 07/2014
3	CateninsIBA 12/2017 - 01/2011
3	Delta CateninIBA 12/2017 - 01/2011
3	Tamoxifen FDA LinkGeneric 07/2014 - 01/2011
3	beta CateninIBA 12/2009 - 01/2007
2	sodium sulfate (sodium bisulfate)FDA LinkGeneric 01/2022 - 01/2018
2	Dextrans (Dextran)FDA Link 01/2022 - 01/2018
2	EnzymesIBA 12/2021 - 11/2006
2	CytokinesIBA 12/2020 - 07/2004
2	Oncogene Proteins (Oncogene Protein)IBA 01/2019 - 03/2004
2	Circular RNAIBA 10/2018 - 11/2016
2	Collagen Type I (Type I Collagen)IBA 05/2017 - 01/2017
2	AntibodiesIBA 01/2016 - 03/2004
2	Caspase 3 (Caspase-3)IBA 04/2014 - 11/2008
2	ThymidineIBA 01/2014 - 01/2013
2	AgarIBA 10/2013 - 08/2004
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 03/2013 - 04/2004
2	DMP 777IBA 12/2012 - 05/2007
2	Celecoxib (Celebrex)FDA Link 12/2011 - 11/2006
2	Heparin-binding EGF-like Growth Factor (HB-EGF)IBA 05/2011 - 04/2003
2	AntigensIBA 06/2010 - 01/2007
2	Heparin (Liquaemin)FDA LinkGeneric 07/2005 - 04/2003
2	MetallothioneinIBA 05/2005 - 07/2004
1	Long Noncoding RNAIBA 12/2022
1	Calcium-Binding ProteinsIBA 02/2022
1	AzoxymethaneIBA 01/2022
1	Small Cytoplasmic RNAIBA 01/2022
1	RNA (Ribonucleic Acid)IBA 01/2022
1	Lactic Acid (Lactate)FDA LinkGeneric 12/2021
1	LipidsIBA 12/2021
1	GlycogenIBA 12/2021
1	1-phenyl-3,3-dimethyltriazene (PDT)IBA 10/2021
1	Cancer VaccinesIBA 10/2021
1	Therapeutic UsesIBA 10/2021
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2021
1	Glycogen Synthase Kinase 3IBA 01/2021
1	matrigelIBA 01/2021
1	Doxycycline (Periostat)FDA LinkGeneric 01/2021
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2021

Therapy/Procedure

14	Therapeutics 01/2022 - 06/2002
4	Drug Therapy (Chemotherapy) 01/2022 - 12/2011
3	Precision Medicine 01/2020 - 04/2014
3	Infusion Pumps (Infusion Pump) 07/2014 - 02/2007
3	Lasers (Laser) 03/2013 - 07/2007
1	Photochemotherapy (Photodynamic Therapy) 10/2021